Biogen (BIIB) Raw Materials (2010 - 2018)
Biogen (BIIB) posted quarterly Raw Materials of $196.3 million for Q4 2018, up 20.87% year-over-year from $162.4 million in Q4 2017, and up 20.87% quarter-over-quarter from $162.4 million in Q4 2017.
Biogen (BIIB) Raw Materials (2010 - 2018) Analysis & Trends
Biogen's Raw Materials history runs 9 years deep, the most recent figure standing at $196.3 million for Q4 2018.
- In Q4 2018, Raw Materials rose 20.87% year-over-year to $196.3 million; the TTM figure through Dec 2018 stood at $196.3 million (up 20.87% YoY), while the FY2018 annual figure was $196.3 million, up 20.87% from the prior year.
- Raw Materials for Q4 2018 stood at $196.3 million, up from $162.4 million in the prior quarter.
- The five-year high for Raw Materials was $213.0 million in Q4 2015, with the low at $128.3 million in Q4 2014.
- The 5-year median for Raw Materials is $170.4 million (2016), against an average of $174.1 million.
- The sharpest annual moves came in 2015 and 2016: Raw Materials soared 66.02% in 2015, then dropped 20.0% in 2016.
- Biogen's Raw Materials stood at $128.3 million in 2014, then jumped by 66.02% to $213.0 million in 2015, then slipped by 20.0% to $170.4 million in 2016, then dropped by 4.69% to $162.4 million in 2017, then gained by 20.87% to $196.3 million in 2018.
- Business Quant data shows BIIB's Raw Materials at $196.3 million in Q4 2018, $162.4 million in Q4 2017, and $170.4 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 196.30 Mn |
| Dec 31, 2017 | 162.40 Mn |
| Dec 31, 2016 | 170.40 Mn |
| Dec 31, 2015 | 213.00 Mn |
| Dec 31, 2014 | 128.30 Mn |
| Dec 31, 2013 | 115.00 Mn |
| Mar 31, 2013 | 109.80 Mn |
| Dec 31, 2012 | 101.80 Mn |
| Jun 30, 2012 | 92.90 Mn |
| Mar 31, 2012 | 90.80 Mn |
| Dec 31, 2011 | 83.80 Mn |
| Dec 31, 2010 | 59.00 Mn |